Figure 4. Evaluation of Ad-stTRAIL as a Therapy for Gliomas.
(A, B, C) The schematic drawing for experimental design and MRI analysis. U87-MG human malignant glioma cells (1×105 cells/10 µL per mouse brain) were stereotactically implanted into the right striatum of athymic mice (nu/nu). 6 and 10 days after tumor implantation, controls (saline or Ad-Ψ5) or Ad-stTRAIL were delivered intra-tumorally. Tumor growth was monitored by MRI at the indicated times. (D) Representative animals treated with Ad-Ψ5 or Ad-stTRAIL.
